Nov 22 (Reuters) - Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to two of Viatris's women's healthcare product ranges.
The Competition and Markets Authority $(CMA)$ said Viatris breached regulations by failing to obtain its consent before altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)
(Reporting by DhanushVignesh Babu in Bengaluru; Editing by Savio D'Souza)
((DhanushVignesh.Babu@thomsonreuters.com;))